RxDoctor Payments Data

Matthew Shirley, MD

Orthopaedic Surgery · Park City, UTNPI 1790280121

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (35.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Smith+Nephew at 24.3% of the total. 2025 is the largest year on record at $20,856, more than ten times the $874 reported in 2019.

$41,235in general payments, 2019–2025

Across 179 payments — averaging $230.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$10K
  • Depuy Synthes Products, Inc.$8K
  • Medical Device Business Services, Inc.$7K
  • Stryker$6K
  • Zimmer Biomet$4K
  • GE HealthCare$3K
  • plus $3K from 7 others

What the payments were for

  • Consulting fees$13,39132%
  • Grants$1,8755%
  • Travel & lodging$14,68236%
  • Food & beverage$9,33523%
  • Education$1,9525%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,235 in reported general payments places this provider in the 85th percentile of 221 orthopaedic surgery providers in Utah.

See all orthopaedic surgery providers in Utah

Medicare billing

Part B allowed, 2024
$79,451
Medicare patients
172
Services billed
1,904

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin12$273
Celecoxib16$256
Oxycodone Hcl20$119
Pantoprazole Sodium18$91
Tramadol Hcl20$90
Hydromorphone Hcl15$68

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Park City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →